Understanding where an innovative solution can add real clinical and economic value is critical when assessing market potential.
Our client, an early-stage precision medicine company in the US, was developing a screening tool for donor selection in oncology transplantation. In order to attract funding and support go-to-market planning, the company needed to understand the tool’s commercial potential in the US market.
We began by examining the economic realities of reimbursement and oncology center budgets to ground our research.
With that foundation, we conducted a status quo assessment to evaluate current costs and reimbursement models for donor selection in oncology transplantation. This analysis highlighted key pain points where the client’s tool could offer value.
Our team also conducted a value and pricing opportunity assessment through targeted expert interviews with payer and provider stakeholders. We used these conversations to gauge interest in the technology and willingness to pay.
To finalize our research, we compared similar precision medicine and transplant tools to set pricing expectations. The technology benchmarking validated our pricing and reimbursement assumptions and formed the basis of our initial pricing strategy.
Investor confidence strengthened and additional funding unlocked.
Our research provided the client with a credible pricing story supported by data. The results were integrated into investor pitches, helping the company convey the tool’s clinical relevance and commercial potential.
Contact us
Our experts are always happy to discuss your issue. Reach out, and we’ll connect you with a member of our team.